Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely designed TPD techniques. In this particular overview, we focus on equally preclinical experiments and clinical trials to offer a comprehensive summary of the protection and clinical efficiency of PROTACs and MGDs in hematologic malignancies in https://at-5600987.ampblogs.com/5-simple-statements-about-ag-1478-explained-68594191